Chlorin E6-Curcumin-Mediated Photodynamic Therapy Promotes an Anti-Photoaging Effect in UVB-Irradiated Fibroblasts.
antioxidant
chlorin e6
curcumin
matrix metalloproteinase
photoaging
photodynamic therapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Aug 2023
30 Aug 2023
Historique:
received:
21
07
2023
revised:
24
08
2023
accepted:
25
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
Skin photoaging due to ultraviolet B (UVB) exposure generates reactive oxygen species (ROS) that increase matrix metalloproteinase (MMP). Chlorin e6-photodynamic therapy (Ce6-PDT), in addition to being the first-line treatment for malignancies, has been shown to lessen skin photoaging, while curcumin is well known for reducing the deleterious effects of ROS. In the current study, PDT with three novel Ce6-curcumin derivatives, a combination of Ce6 and curcumin with various linkers, including propane-1,3-diamine for Ce6-propane-curcumin; hexane-1,6-diamine for Ce6-hexane-curcumin; and 3,3'-((oxybis(ethane-2,1-diyl))bis(oxy))bis(propan-1-amine) for Ce6-dipolyethylene glycol (diPEG)-curcumin, were studied for regulation of UVB-induced photoaging on human skin fibroblast (Hs68) and mouse embryonic fibroblast (BALB/c 3T3) cells. We assessed the antiphotoaging effects of Ce6-curcumin derivatives on cell viability, antioxidant activity, the mechanism of matrix metalloproteinase-1 and 2 (MMP-2) expression, and collagen synthesis in UVB-irradiated in vitro models. All three Ce6-curcumin derivatives were found to be non-phototoxic in the neutral red uptake phototoxicity test. We found that Ce6-hexane-curcumin-PDT and Ce6-propane-curcumin-associated PDT exhibited less cytotoxicity in Hs68 and BALB/c 3T3 fibroblast cell lines compared to Ce6-diPEG-curcumin-PDT. Ce6-diPEG-curcumin and Ce6-propane-curcumin-associated PDT showed superior antioxidant activity in Hs68 cell lines. Further, in UVB-irradiated in vitro models, the Ce6-diPEG-curcumin-PDT greatly attenuated the expression levels of MMP-1 and MMP-2 by blocking mitogen-activated protein kinases (MAPKs), activator protein 1 (AP-1), and tumor necrosis factor-α (NF-κB) signaling. Moreover, Ce6-diPEG-curcumin effectively inhibited inflammatory molecules, such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression, while accelerating collagen synthesis. These results demonstrate that Ce6-diPEG-curcumin may be a potential therapy for treating skin photoaging.
Identifiants
pubmed: 37686273
pii: ijms241713468
doi: 10.3390/ijms241713468
pmc: PMC10487708
pii:
doi:
Substances chimiques
Curcumin
IT942ZTH98
n-hexane
2DDG612ED8
Hexanes
0
Matrix Metalloproteinase 2
EC 3.4.24.24
phytochlorin
5S2CCF3T1Z
Antioxidants
0
Propane
T75W9911L6
Reactive Oxygen Species
0
Glycols
0
Collagen
9007-34-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : This work was supported by the Technology development Program (S3034405) funded by the Ministry of SMEs and Startups (MSS, Korea).
ID : S3034405
Références
Rev Environ Health. 2014;29(3):243-54
pubmed: 25241726
Photodiagnosis Photodyn Ther. 2020 Sep;31:101917
pubmed: 32659375
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):2015-2025
pubmed: 28499917
Biomolecules. 2015 Apr 21;5(2):545-89
pubmed: 25906193
Int J Mol Sci. 2021 Apr 12;22(8):
pubmed: 33921444
J Invest Dermatol. 2022 Jun;142(6):1670-1681.e12
pubmed: 34740582
RSC Adv. 2022 Feb 2;12(7):4094-4100
pubmed: 35425448
Photodiagnosis Photodyn Ther. 2012 Jun;9(2):164-9
pubmed: 22594987
Br J Dermatol. 2007 Nov;157(5):874-87
pubmed: 17711532
Clin Interv Aging. 2018 Apr 26;13:757-772
pubmed: 29731617
Angew Chem Int Ed Engl. 2020 Jan 2;59(1):61-73
pubmed: 31310436
Mol Med Rep. 2019 Sep;20(3):2945-2953
pubmed: 31524245
Am J Transl Res. 2015 Feb 15;7(2):298-308
pubmed: 25901198
Br J Dermatol. 2011 Jul;165(1):144-51
pubmed: 21615716
Biogerontology. 2020 Jun;21(3):293-310
pubmed: 32162126
Methods Mol Biol. 2012;878:121-35
pubmed: 22674130
Mar Drugs. 2020 Aug 15;18(8):
pubmed: 32824148
JCI Insight. 2022 May 9;7(9):
pubmed: 35316219
Radiat Res. 1998 Nov;150(5 Suppl):S146-56
pubmed: 9806617
Life (Basel). 2022 Dec 15;12(12):
pubmed: 36556479
Sci Rep. 2017 Mar 15;7:44537
pubmed: 28295043
Rejuvenation Res. 2010 Aug;13(4):397-410
pubmed: 20426620
Appl Neuropsychol Child. 2017 Jan-Mar;6(1):79-94
pubmed: 27049546
Pharmaceutics. 2022 Apr 30;14(5):
pubmed: 35631555
Foods. 2017 Oct 22;6(10):
pubmed: 29065496
Mol Med Rep. 2018 May;17(5):7227-7237
pubmed: 29568864
Molecules. 2021 Aug 07;26(16):
pubmed: 34443381
Photochem Photobiol Sci. 2022 Dec;21(12):2217-2230
pubmed: 36103110
Int J Mol Sci. 2019 Mar 12;20(5):
pubmed: 30871021
J Agric Food Chem. 2001 Oct;49(10):4619-26
pubmed: 11599998
Exp Dermatol. 2013 May;22(5):371-4
pubmed: 23614750
Chem Rec. 2017 Aug;17(8):775-802
pubmed: 28042681
J Cosmet Dermatol. 2018 Apr;17(2):124-137
pubmed: 29575554
J Cosmet Dermatol. 2007 Sep;6(3):189-94
pubmed: 17760698
Clin Endosc. 2013 Jan;46(1):7-23
pubmed: 23423543
Int J Mol Sci. 2016 Jun 02;17(6):
pubmed: 27271600
J Invest Dermatol. 2013 May;133(5):1362-6
pubmed: 23466932
Food Chem Toxicol. 2020 Feb;136:110963
pubmed: 31715308
PLoS One. 2017 Jan 24;12(1):e0170599
pubmed: 28118375
Photodiagnosis Photodyn Ther. 2021 Mar;33:102181
pubmed: 33429100
J Biomol Struct Dyn. 2022 Mar;40(5):2339-2351
pubmed: 33103592
Int J Mol Sci. 2019 Feb 27;20(5):
pubmed: 30818884
Pharmaceutics. 2023 May 23;15(6):
pubmed: 37376026
Am J Dermatopathol. 2019 Jul;41(7):469-479
pubmed: 31232733
Cells. 2022 Dec 10;11(24):
pubmed: 36552759
Nucleic Acids Res. 2022 Jul 5;50(W1):W159-W164
pubmed: 35609983
CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81
pubmed: 21617154
Eur J Med Chem. 2018 Mar 10;147:66-76
pubmed: 29421571
Antioxidants (Basel). 2022 Jan 24;11(2):
pubmed: 35204104
Mar Drugs. 2022 Apr 30;20(5):
pubmed: 35621960
Front Pharmacol. 2021 Aug 30;12:728261
pubmed: 34526903